Although upper-extremity deep vein thrombosis (UEDVT) is considered rare, its prevalence appears to be increasing, and this may be related to expanding indications for catheter-based interventions. In contrast, few cases have been reported related to strenuous exercise, especially in healthy young adults with thoracic outlet syndrome (Paget-Schroetter syndrome). In contrast to lower-extremity DVT, optimal treatment strategies for UEDVT have not been robustly studied. In this report, we describe a 56-year-old man with primary UEDVT presenting with left arm swelling, paresthesia, and visible collateral veins around the shoulder. Venography revealed thrombotic occlusion of the left subclavian vein. Emergent pharmaco-mechanical catheter-directed thrombolysis (PCDT) was performed, and his left subclavian vein was recanalized. A novel oral anticoagulant was initiated to prevent reclosure. The patient's symptoms subsided without major bleeding complications and at six months, he has no disability for daily activities. Follow-up ultrasonography revealed almost complete patency of the left subclavian vein, after which anticoagulation therapy was terminated. We discuss the role of PCDT in the management of primary UEDVT from the perspective of efficacy and contribution to quality of life. < UEDVT is relatively rare and has not been examined as extensively as lower-extremity DVT. Nonetheless, patients may have a variety of unpleasant symptoms that substantially decrease quality of life. Pharmaco-mechanical catheter-directed thrombolysis may be effective to reduce clot burden and mitigate the risk of post-thrombotic syndrome. Although there is no current consensus about exact indications for UEDVT patients, the procedure may be more useful than the standard anticoagulant therapy.>.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149553PMC
http://dx.doi.org/10.1016/j.jccase.2017.08.001DOI Listing

Publication Analysis

Top Keywords

pharmaco-mechanical catheter-directed
12
catheter-directed thrombolysis
12
left subclavian
12
subclavian vein
12
deep vein
8
vein thrombosis
8
lower-extremity dvt
8
primary uedvt
8
quality life
8
uedvt
6

Similar Publications

Endovascular management of acute and subacute venous thoracic outlet syndrome.

Front Surg

February 2024

Division of Vascular and Endovascular Surgery, Medical College of Wisconsin, Milwaukee, WI, United States.

Approximately 3% of all patients presenting with Thoracic Outlet Syndrome have a venous etiology (vTOS), which is considered "effort thrombosis". These patients will present with symptomatic deep venous thrombosis or focal subclavian vein (SCV) stenosis. Endovascular management of vTOS occurs in several phases: diagnostic, preoperative therapeutic intervention before decompression, postoperative interventions after decompression, and delayed interventions in the follow-up after decompression.

View Article and Find Full Text PDF

Inferior vena cava thrombosis (IVCT) is rare. Thrombophilia is one of the important risk factors. It is also uncommon for gene mutations in F9 gene to cause thrombosis but not hemorrhage.

View Article and Find Full Text PDF

The background and role of catheter-directed thrombolysis evolving procedures for acute iliofemoral deep venous thrombosis.

J Cardiovasc Surg (Torino)

February 2024

Department of Vascular and Endovascular Surgery, Erasmus Medical Center, Rotterdam, the Netherlands.

Minimal invasive treatment such as early endovenous thrombus removal for iliofemoral deep venous thrombosis (DVT) emerged in the end of last century. The principle is catheter-directed thrombolysis (CDT) using either plasminogen activating agents alone, as ultrasound-assisted CDT, or in combination with mechanical devices as pharmaco-mechanical CDT. The interest for this treatment modality is the high rate of post-thrombotic syndrome (PTS) with anticoagulation (AC) alone, especially after iliofemoral DVT.

View Article and Find Full Text PDF

Pharmaco-mechanical thrombectomy (PMT) and catheter-directed thrombolysis (CDT) are therapeutic options for selected patients with acute deep vein thrombosis (DVT) to prevent post-thrombotic syndrome (PTS). We aimed to describe the clinical characteristics and outcomes of 159 patients with symptomatic iliofemoral DVT undergoing PMT alone, CDT alone, or CDT followed by PMT (bail-out) in the Swiss Venous Stent Registry. The primary outcome was the incidence of peri-interventional major and minor bleeding complications (ISTH criteria).

View Article and Find Full Text PDF

Pulmonary embolism (PE) is a common disease associated with high morbidity and mortality. Currently, guidelines recommend systemic thrombolysis in patients with haemodynamic instability (high-risk PE) or patients with intermediate-high-risk PE with haemodynamic deterioration. Nevertheless, more than half of high-risk PE patients do not receive systemic thrombolysis due to a perceived increased risk of bleeding.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!